Mirus Bio Corporation, a life science company, discovers, develops, and commercializes nucleic acid based technologies and products. It provides transfection reagents, electroporation kits and solutions, DNA and RNA labeling reagents, in vivo delivery products, and accessories. The company offers its products through distributors in Argentina,Australia, Austria, Belgium, Bangladesh, Canada, Chile, the People's Republic of China, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Iceland, India, Indonesia, Ireland, Israel, Japan, Korea, Malaysia, the Netherlands, New Zealand, Norway, the Philippines, Portugal, Singapore, Slovenia, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, the United Kingdom, the United States, and Vietnam. Mirus Bio Corporation was formerly known as Mirus Corporation. The company was founded in 1995 and is based in Madison, Wisconsin. As of September 30, 2008, Mirus Bio Corporation operates as a subsidiary of Roche Holding AG.

Life Sciences

Health Care

Biotechnology

Mirus Bio

Dale Gordon

Laura Juckem

Scott Hinkelman, CPA

Nat Connors

Miguel Dominguez

Jena Lange

Geoffrey B. Schwartz, MBA

Claire Dacombe

The Leadership Team at Mirus Bio is responsible for strategic direction and operational oversight, focusing on driving growth and innovation in nucleic acid-based technologies. Comprising the CEO, Chief Commercial Officer, and Vice Presidents for Asia Pacific and Research & Development, this team collaborates to enhance product development, expand global market reach, and ensure alignment with the company’s mission to advance life science solutions.

Leadership Team

Research and Development

Sales and Account Management

Leadership Team

About

Team members

Other teams at Mirus Bio

Research and Development

Sales and Account Management